1
|
Olorunfemi G, Ndlovu N, Masukume G,
Chikandiwa A, Pisa PT and Singh E: Temporal trends in the
epidemiology of cervical cancer in South Africa (1994–2012). Int J
Cancer. 143:2238–2249. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Brinton LA, Sherman ME, Carreon JD and
Anderson WF: Recent trends in breast cancer among younger women in
the United States. J Natl Cancer Inst. 100:1643–1648. 2008.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Huang Z, Zheng Y, Wen W, Wu C, Bao P, Wang
C, Zhong W, Gao YT, Jin F, Xiang YB, et al: Incidence and mortality
of gynaecological cancers: Secular trends in urban Shanghai, China
over 40 years. Eur J Cancer. 63:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gomez SL, Von Behren J, McKinley M, Clarke
CA, Shariff- Marco S, Cheng I, Reynolds P and Glaser SL: Breast
cancer in Asian Americans in California, 1988–2013: Increasing
incidence trends and recent data on breast cancer subtypes. Breast
Cancer Res Treat. 164:139–147. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Aareleid T, Zimmermann ML, Baburin A and
Innos K: Divergent trends in lung cancer incidence by gender, age
and histological type in Estonia: A nationwide population-based
study. BMC Cancer. 17:5962017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
7
|
Roness H, Kashi O and Meirow D: Prevention
of chemotherapy-induced ovarian damage. Fertil Steril. 105:20–29.
2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Donnez J and Dolmans MM: Fertility
preservation in women. N Engl J Med. 377:1657–1665. 2017.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Sofias AM, Dunne M, Storm G and Allen C:
The battle of ‘nano’ paclitaxel. Adv Drug Deliv Rev. 122:20–30.
2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Koh WJ, Abu-Rustum NR, Bean S, Bradley K,
Campos SM, Cho KR, Chon HK, Chu C, Clark R, Cohn D, et al: Cervical
cancer, version 3.2019, NCCN clinical practice guidelines in
oncology. J Natl Compr Canc Netw. 17:64–84. 2019. View Article : Google Scholar : PubMed/NCBI
|
11
|
Gradishar WJ, Anderson BO, Abraham J, Aft
R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD,
et al: Breast cancer, version 3.2020, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 18:452–478. 2020.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Ettinger DS, Wood DE, Aggarwal C, Aisner
DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac
LR, et al: NCCN guidelines insights: Non-small cell lung cancer,
version 1.2020. J Natl Compr Canc Netw. 17:1464–1472. 2019.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Alushin GM, Lander GC, Kellogg EH, Zhang
R, Baker D and Nogales E: High-resolution microtubule structures
reveal the structural transitions in αβ-tubulin upon GTP
hydrolysis. Cell. 157:1117–1129. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Mailhes JB, Carabatsos MJ, Young D, London
SN, Bell M and Albertini DF: Taxol-induced meiotic maturation
delay, spindle defects, and aneuploidy in mouse oocytes and
zygotes. Mutat Res. 423:79–90. 1999. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ozcelik B, Turkyilmaz C, Ozgun MT, Serin
IS, Batukan C, Ozdamar S and Ozturk A: Prevention of paclitaxel and
cisplatin induced ovarian damage in rats by a
gonadotropin-releasing hormone agonist. Fertil Steril.
93:1609–1614. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gücer F, Balkanli-Kaplan P, Doganayl, Yüce
MA, Demiralay E, Sayin NC and Yardim T: Effect of paclitaxel on
primordial follicular reserve in mice. Fertil Steril. 76:628–629.
2001. View Article : Google Scholar : PubMed/NCBI
|
17
|
Tarumi W, Suzuki N, Takahashi N, Kobayashi
Y, Kiguchi K, Sato K and Ishizuka B: Ovarian toxicity of paclitaxel
and effect on fertility in the rat. J Obstet Gynaecol Res.
35:414–420. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kai S, Kohmura H, Hiraiwa E, Koizumi S,
Ishikawa K, Kawano S, Kuroyanagi K, Hattori N, Chikazawa H, Kondoh
H, et al: Reproductive and developmental toxicity studies of
paclitaxel. (I)-Intravenous administration to rats prior to and in
the early stages of pregnancy. J Toxicol Sci. 19 (Suppl 1):S57–S67.
1994.(In Japanese). View Article : Google Scholar
|
19
|
Reh A, Oktem O and Oktay K: Impact of
breast cancer chemotherapy on ovarian reserve: A prospective
observational analysis by menstrual history and ovarian reserve
markers. Fertil Steril. 90:1635–1639. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhao J, Liu J, Chen K, Li S, Wang Y, Yang
Y, Deng H, Jia W, Rao N, Liu Q and Su F: What lies behind
chemotherapy-induced amenorrhea for breast cancer patients: A
meta-analysis. Breast Cancer Res Treat. 145:113–128. 2014.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Hamy AS, Porcher R, Eskenazi S, Cuvier C,
Giacchetti S, Coussy F, Hocini H, Tournant B, Perret F, Bonfils S,
et al: Anti-mullerian hormone in breast cancer patients treated
with chemotherapy: A retrospective evaluation of subsequent
pregnancies. Reprod Biomed Online. 32:299–307. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Sukumvanich P, Case LD, Van Zee K,
Singletary SE, Paskett ED, Petrek JA, Naftalis E and Naughton MJ:
Incidence and time course of bleeding after long-term amenorrhea
after breast cancer treatment: A prospective study. Cancer.
116:3102–3111. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Silva C, Caramelo O, Almeida-Santos T and
Ribeiro Rama AC: Factors associated with ovarian function recovery
after chemotherapy for breast cancer: A systematic review and
meta-analysis. Hum Reprod. 31:2737–2749. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Senra JC, Roque M, Talim MCT, Reis FM and
Tavares RLC: Gonadotropin-releasing hormone agonists for ovarian
protection during cancer chemotherapy: Systematic review and
meta-analysis. Ultrasound Obstet Gynecol. 51:77–86. 2018.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Munhoz RR, Pereira AA, Sasse AD, Hoff PM,
Traina TA, Hudis CA and Marques RJ: Gonadotropin-releasing hormone
agonists for ovarian function preservation in premenopausal women
undergoing chemotherapy for early-stage breast cancer: A systematic
review and meta-analysis. JAMA Oncol. 2:65–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
National Institutes of Health (NIH),
Animal Research Advisory Committee, . NIH Guidelines for Endpoints
in Animal Study Proposals. NIH; Bethesda, MD: 2016
|
27
|
Wang XN, Roy SK and Greenwald GS: In vitro
DNA synthesis by isolated preantral to preovulatory follicles from
the cyclic mouse. Biol Reprod. 44:857–863. 1991. View Article : Google Scholar : PubMed/NCBI
|
28
|
Cardiff RD, Miller CH and Munn RJ: Manual
hematoxylin and eosin staining of mouse tissue sections. Cold
Spring Harb Protoc. 2014:655–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Myers M, Britt KL, Wreford NG, Ebling FJ
and Kerr JB: Methods for quantifying follicular numbers within the
mouse ovary. Reproduction. 127:569–580. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Tinwell H and Ashby J: Genetic toxicity
and potential carcinogenicity of taxol. Carcinogenesis.
15:1499–1501. 1994. View Article : Google Scholar : PubMed/NCBI
|
31
|
Oktem O and Urman B: Understanding
follicle growth in vivo. Hum Reprod. 25:2944–2954. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Rezazadeh M, Emam J, Mostafavi A, Rostami
M, Hassanzadeh F, Sadeghi H, Minaiyan M and Lavasanifar A: A rapid
and sensitive HPLC method for quantitation of paclitaxel in
biological samples using liquid-liquid extraction and UV detection.
Application to pharmacokinetics and tissues distribution study of
paclitaxel loaded targeted polymeric micelles in tumor bearing
mice. J Pharm Pharm Sci. 18:647–660. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Kim JE and Park YJ: Paclitaxel-loaded
hyaluronan solid nanoemulsions for enhanced treatment efficacy in
ovarian cancer. Int J Nanomedicine. 12:645–658. 2017. View Article : Google Scholar : PubMed/NCBI
|
34
|
Anwar M, Akhter S, Mallick N, Mohapatra S,
Zafar S, Rizvi MMA, Ali A and Ahmad FJ: Enhanced anti-tumor
efficacy of paclitaxel with PEGylated lipidic nanocapsules in
presence of curcumin and poloxamer: In vitro and in vivo studies.
Pharmacol Res. 113:(Pt A). 146–165. 2016. View Article : Google Scholar : PubMed/NCBI
|
35
|
Coticchio G, Dal Canto M, Mignini Renzini
M, Guglielmo MC, Brambillasca F, Turchi D, Novara PV and Fadini R:
Oocyte maturation: Gamete-somatic cells interactions, meiotic
resumption, cytoskeletal dynamics and cytoplasmic reorganization.
Hum Reprod Update. 21:427–454. 2015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Oktem O and Oktay K: The ovary: Anatomy
and function throughout human life. Ann N Y Acad Sci. 1127:1–9.
2008. View Article : Google Scholar : PubMed/NCBI
|
37
|
Capalbo A, Hoffmann ER, Cimadomo D, Ubaldi
FM and Rienzi L: Human female meiosis revised: New insights into
the mechanisms of chromosome segregation and aneuploidies from
advanced genomics and time-lapse imaging. Hum Reprod Update.
23:706–722. 2017. View Article : Google Scholar : PubMed/NCBI
|
38
|
Sun QY, Lai L, Wu GM, Park KW, Day BN,
Prather RS and Schatten H: Microtubule assembly after treatment of
pig oocytes with taxol correlation with chromosomes, gamma-tubulin,
and MAP Kinase. Mol Reprod Dev. 60:481–490. 2001. View Article : Google Scholar : PubMed/NCBI
|
39
|
Blumenfeld Z and von Wolff M:
GnRH-analogues and oral contraceptives for fertility preservation
in women during chemotherapy. Hum Reprod Update. 14:543–552. 2008.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Meirow D, Dor J, Kaufman B, Shrim A,
Rabinovici J, Schiff E, Raanani H, Levron J and Fridman E: Cortical
fibrosis and blood-vessels damage in human ovaries exposed to
chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod.
22:1626–1633. 2007. View Article : Google Scholar : PubMed/NCBI
|
41
|
Blumenfeld Z: How to preserve fertility in
young women exposed to chemotherapy? The role of GnRH agonist
cotreatment in addition to cryopreservation of embrya, oocytes, or
ovaries. Oncologist. 12:1044–1054. 2007. View Article : Google Scholar : PubMed/NCBI
|
42
|
Elgindy EA, El-Haieg DO, Khorshid OM,
Ismail EI, Abdelgawad M, Sallam HN and Abou-Setta AM: Gonadatrophin
suppression to prevent chemotherapy-induced ovarian damage: A
randomized controlled trial. Obstet Gynecol. 121:78–86. 2013.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Ethics Committee of American Society for
Reproductive Medicine, . Fertility preservation and reproduction in
patients facing gonadotoxic therapies: A committee opinion. Fertil
Steril. 100:1224–1231. 2013. View Article : Google Scholar : PubMed/NCBI
|
44
|
Loren AW, Mangu PB, Beck LN, Brennan L,
Magdalinski AJ, Partridge AH, Quinn G, Wallace WH and Oktay K;
American Society of Clinical Oncology, : Fertility preservation for
patients with cancer: American society of clinical oncology
clinical practice guideline update. J Clin Oncol. 31:2500–2510.
2013. View Article : Google Scholar : PubMed/NCBI
|
45
|
Morgan RJ Jr, Armstrong DK, Alvarez RD,
Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA,
DeRosa M, Dorigo O, et al: Ovarian cancer, version 1.2016, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
14:1134–1163. 2016. View Article : Google Scholar : PubMed/NCBI
|